U.S. drug approvals hit a 21-year high in 2017, with 46 novel medicines winning a green light -- more than double the previous year -- while the figure also rose in the European Union."New drug approvals hit 21-year high in 2017" via FOX BIZ http://ift.tt/2DPVsEJ
No comments:
Post a Comment